I am long this stock since Dec. '23.
For the last 12 years CERS has behaved in a cyclical manner. I plotted multi-pivot and maximum excursion lines in solid and dashed yellow. These lines conservatively characterize the range's boundaries and reveal that it's expanding. The black 2.5 year down trend line has been violated and retested. I plotted a down sloping...
Positive news on phase 3 trials.
Possible US food & drug admin application next year 2025
8.5 times the usual 20 daily volume average.
Red to green reversal.
This all points towards likely higher prices. If their application next year gets approved expect a monster move. Investors will likely try to front run this.
On the daily chart, the trend started on May 19 (linear regression channel).
There is a high probability of profit. Possible take profit level is 2.98
But do not forget about the SL = 1.74
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am very interested in it. Thank you!
Good Luck!
Regards, WeBelieveInTrading
An additional example of "aligning" timeframes with Moxie.
Here we pass on an initial trampoline setup as hourly is
not quite ready. By waiting, the entry area is much
closer to the subsequent desired move in price.
As noted on chart, simply one approach.
Hopefully this provides some insight(s).
Cerus company
Industry: Health
Industry: Biotechnology and pharmaceuticals
By the end of 2000 the stock had peaked at $ 81.88
From the beginning of 2021 the stock has been on sale until 2004
A down trend has ended since we are in the trading range (accumulation?) Of about 17 years
I have been following the stock for a year
After identifying the up trust in...
if 8-9 resistance clears we can target 14 in 2021.. my honest opinion though, this stocks been in the 2-10 range for almost 20 years! this is crazy :o theres nothing stopping it from going 2-10 for 30 years D: this is why i love breakouts . goodluck though :)
This is a Bullish indicator signaling CERS's price could rise from here. Traders may explore going long the stock or buying call options. I identified 41 similar cases where CERS's MACD histogram became positive, and 34 of them led to successful outcomes. Odds of Success: 83%.
